Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene

Human obesity has an inherited component, but in contrast to rodent obesity, precise genetic defects have yet to be defined¹. A mutation of carboxypeptidase E (CPE), an enzyme active in the processing and sorting of prohormones, causes obesity in the fat/fat mouse^2,3. We have previously described a woman with extreme childhood obesity (Fig. 1), abnormal glucose homeostasis, hypogonadotrophic hypogonadism, hypocortisolism and elevated plasma proinsulin and pro-opiomelanocortin (POMC) concentrations but a very low insulin level, suggestive of a defective prohormone processing by the endopeptidase, prohormone convertase 1 (PC1; ref. 4). We now report this proband to be a compound heterozygote for mutations in PC1. GlyArg483 prevents processing of proPd and leads to its retention in the endoplasmic reticulum (ER). AC⁺⁴ of the intron-5 donor splice site causes skipping of exon 5 leading to loss of 26 residues, a frameshift and creation of a premature stop codon within the catalytic domain. PC1 acts proximally to CPE in the pathway of post-translational processing of prohormones and neuropeptides. In view of the similarity between the proband and the fat/fat mouse phenotype, we infer that molecular defects in prohormone conversion may represent a generic mechanism for obesity, common to humans and rodents.

1. Spiegelman, B.M. & Flier, J.S. Adipogenesis and obesity: founding out the big picture. Cell 87, 377−389 (1996). | Article | PubMed  | ISI | ChemPort |
2. Naggert, J.K. et al. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nature Genet. 10, 135−142 (1995). | Article | PubMed  | ISI | ChemPort |
3. Cool, D.R. et al. Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpe^fat mice. Cell 88, 73−83 (1997). | Article | PubMed  | ISI | ChemPort |
4. O'Rahilly, S. et al. Impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N. Engl. J. Med. 333, 1386−1390 (1995). | Article | PubMed  | ChemPort |
5. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K. & Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA. 86, 2766−2770 (1989). | PubMed  | ChemPort |
6. Ohagi, S. et al. Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM. Diabetes 45, 897−901 (1996). | PubMed  | ISI |
7. Mount, S.A catalogue of splice junction sequences. Nucleic Adds Res. 10, 459−472 (1982). | ChemPort |
8. Krawczak, M., Reiss, J. & Cooper, N. The mutational spectum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 90, 41−54 (1992). | PubMed  | ISI | ChemPort |
9. Scriver, C.R., Beaudet, A.L., Sly, W. S. & Valle, D. The Metabolic and Molecular Basis of Inherited Disease. 269−270 McGraw-Hill, New York,(1995).
10. Zhou, Y. & Lindberg, I. Purification and characterization of the prohormone convertase PC1 (PC3). J. Biol. Chem. 268, 5615−5623 (1993). | PubMed  | ChemPort |
11. Creemers, J.W. et al. Endoproteolytic cleavage of its propeptide is a prerequisite for the efficient transport of f urin out of the endoplasmic reticulum. J. Biol. Chem. 270, 2695−702 (1995). | Article | PubMed  | ISI | ChemPort |
12. Taylor, N.A., Shennan, K.I.J., Cutler, D.F. & Docherty, K. Mutations within the propeptide, the primary cleavage site or the catalytic site, or deletion of C-terminal sequences, prevents secretion of proPC2 from transfected COS-7 cells. Biochem. J. 321, 367−373 (1997). | PubMed  | ISI | ChemPort |
13. Davidson, H.W., Rhodes, C.J. & Mutton, J.C. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic cell via two distinct site-specific endopeptidases. Nature 333, 93−96 (1988). | Article | PubMed  | ISI | ChemPort |
14. Rouille, Y. et al. Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front. Endocrinol. 16, 322−361 (1995). | ChemPort |
15. Fricker, L.D., Berman, Y.L., Leiter, E.H. & Devi, L. A. Carboxypeptidase E activity is deficient in mice with the fat mutation. J. Biol. Chem. 271, 30619−30624 (1996). | Article | PubMed  | ISI | ChemPort |
16. Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J. & Cone, R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165−168 (1997). | Article | PubMed  | ISI | ChemPort |
17. Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131−141 (1997). | Article | PubMed  | ISI | ChemPort |
18. Turton, M.D. et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69−72 (1996). | Article | PubMed  | ISI | ChemPort |
19. Zaidi, F.K. et al. Homozygosity for a common polymorphism in the islet-specific promotor of the glucokinase gene is associated with a reduced early insulin response to oral glucose in pregnant women. Diabet Med. 14, 228−234 (1997). | Article | PubMed  | ISI | ChemPort |
20. Creemers, J.W., Roebroek, A.J. & Van-de-Ven, W.J. Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3. Cloning and primary sequence of a 5kb cDNA. FEBS Lett. 300, 82−88 (1992). | Article | PubMed  | ISI | ChemPort |
21. Creemers, J.W. et al. Modulation of furin-mediated proprotein processing activity by site-directed mutagenesis. Biol. Chem. 268, 21826−21834 (1993). | ChemPort |
22. Creemers, J.W. et al. Identification of a transferable sorting domain for the regulated pathway in the prohormone convertase PC2. J. Biol. Chem. 271, 25284−25291 (1997). | ISI |

	Top

	Top